Heitz, Florian <br/><br/>
Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.  [electronic resource] 

 -  Expert review of anticancer therapy  Jul 2010 
 - 1125-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1586/era.10.53  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis Regulatory Proteins<br/>BRCA1 Protein--deficiency<br/>BRCA2 Protein--deficiency<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>DNA Breaks, Single-Stranded<br/>DNA Repair<br/>DNA, Neoplasm--metabolism<br/>Drug Delivery Systems<br/>Drug Resistance, Neoplasm<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Multicenter Studies as Topic<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Ovarian Neoplasms--drug therapy<br/>PTEN Phosphohydrolase--deficiency<br/>Poly (ADP-Ribose) Polymerase-1<br/>Poly Adenosine Diphosphate Ribose--metabolism<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Poly(ADP-ribose) Polymerases--physiology